Top

Published in:

01-03-2002 | Original Article

Killing activity of human umbilical cord blood-derived TCRValpha24⁺ NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells

Authors: Masao Hagihara, Balgansuren Gansuvd, Yoko Ueda, Takahide Tsuchiya, Aya Masui, Kei Tazume, Hiroyasu Inoue, Shunichi Kato, Tomomitsu Hotta

Published in: Cancer Immunology, Immunotherapy | Issue 1/2002

Title: Killing activity of human umbilical cord blood-derived TCRValpha24+ NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells
Authors: Masao Hagihara
Balgansuren Gansuvd
Yoko Ueda
Takahide Tsuchiya
Aya Masui
Kei Tazume
Hiroyasu Inoue
Shunichi Kato
Tomomitsu Hotta
Publication date: 01-03-2002
Publisher: Springer-Verlag
Published in: Cancer Immunology, Immunotherapy / Issue 1/2002
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-001-0246-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2002

Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells

The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation

Binding to CD20 by Anti-B1 Antibody or F(ab')2 is sufficient for induction of apoptosis in B-cell lines

Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial

Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK

A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer